Market Overview
The Canadian animal healthcare market encompasses veterinary pharmaceuticals, biologicals (vaccines), diagnostics, and clinical services delivered across companion and livestock animal populations. Multiple market-research estimates converge on a 2025 market size near USD 2.9 billion, though no single Canadian federal agency publishes an integrated market total. The market reflects a mature North American healthcare ecosystem regulated by Health Canada and the Canadian Food Inspection Agency (CFIA).
- •Estimated market size of approximately USD 2.98 billion in 2025, with historical baselines around USD 2.65-2.8 billion
- •Growth rates reported in the 6.9% to 7.3% CAGR range by various research estimates through 2030-2033
- •Government data is collected through separate agricultural and pet expenditure surveys rather than a unified industry measure
Growth Drivers
Rising pet ownership and humanization of companion animals in urban Canada is a primary engine, with Canadians spending more per animal on preventive care and treatments. Livestock and agricultural production pressures, including food security and disease management requirements, sustain demand in the farm animal segment. Advances in veterinary diagnostics, digital health tools, and the availability of specialty therapies also contribute to ongoing market expansion.
- •Companion animal segment projected to grow at approximately 12.4% CAGR, significantly outpacing the overall market
- •Veterinary diagnostics sub-segment valued at USD 232.4 million in 2025, expected to reach USD 316.7 million by 2030
- •Regulatory frameworks from Health Canada and the CFIA maintain product approval pathways that shape market entry and access
Segmentation and Regional Analysis
The market splits into companion animal healthcare and livestock/agricultural animal healthcare, with companion animals representing a rapidly growing share. Companion animal revenue was estimated at roughly USD 1.14 billion in 2025, driven by high urban pet ownership in provinces such as Ontario, British Columbia, and Quebec. The livestock segment remains substantial but grows more modestly, supported by Canada's agricultural economy spanning prairie provinces and dairy-producing regions.
- •Companion animal healthcare: ~USD 1.14 billion in 2025; projected to reach ~USD 2.9 billion by 2033 at ~12.4% CAGR
- •Veterinary diagnostics segment: USD 232.4 million (2025) with 6.4% CAGR, supported across both urban and rural care infrastructure
- •Regional concentration in major population centers, with agricultural demand centered in Western Canada's farm communities
Trends and Outlook
What are the recent trends and outlook?
The companion animal healthcare segment is expected to remain the fastest-growing area of the Canadian market through the early 2030s, reflecting broader societal trends in pet ownership. Advances in precision animal health, digital veterinary platforms, and specialty pet therapies are likely to reshape service delivery and product mix. Market estimates vary in their long-range projections, with some forecasting the total Canadian market reaching between USD 4.2 billion and USD 5.2 billion by 2030-2033, contingent on economic conditions, regulatory developments, and animal health spending patterns.
- •Companion animal care, including nutrition, pharmaceuticals, and advanced diagnostics, expected to drive disproportionate share of future growth
- •Emerging emphasis on preventive care, telemedicine, and digital health solutions within veterinary practice settings
- •Long-range market projections span USD 4.23 billion (by 2030) to USD 5.15 billion (by 2033), reflecting differing methodological assumptions across sources
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.